LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

The Beckley Foundation and its founder Amanda Feilding announced a new research program with King's College London and UCL on the effects of full dose LSD as well as a breakthrough study with the ...

The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...

For a couple of freewheeling years, two young Harvard psychologists have carried on wide-ranging experiments with mind-altering drugs. At the university’s Center for Research in Personality, they sent ...

Patients who participate in the MM-120 study at Segal Trials’ Center for Psychedelic and Cannabis Research in Miami Lakes will be dosed and observed in a room made to resemble more of a home than a ...

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy status to an LSD formula to treat generalized anxiety disorder after an initial study has shown that a single dose of the ...

According to new research, psychedelic-assisted therapy could be a surprisingly effective and long-lasting treatment for anxiety and depression-related symptoms. As detailed in a new study published ...

A series of three new research projects announced this week will seek to illuminate our understanding of microdosing LSD. The research is being spearheaded by The Beckley Foundation and its founder, ...

Move over Xanax, Prozac, and Duloxetine? A recent study comparing a single oral dose of MM120 (LSD) with a placebo suggests that LSD may be an effective treatment for anxiety. Lysergic acid ...

Move over Xanax, Prozac, and Duloxetine? A recent study comparing a single oral dose of MM120 (LSD) with a placebo suggests that LSD may be an effective treatment for anxiety. Lysergic acid ...